维普中文期刊产品整合服务
12篇 您的检索式:作者名="WEINTRAUB HS"
    题名 作者 年代 出处 被引量
1Short in vitro half-life of thymopoietin 32-36 pentapeptide in human plasma显示文摘Tischio JP Patrick JE Weintraub Hs 0,,05:1
2Identifying the vulnerable patient with rupture- prone plaque 显示文摘Weintraub HS 2008Am J Cardiol2008,101,:1
3Identifying the vulnerable patient with ruptureprone plaque显示文摘Weintraub HS 2008Am J Cardiol2008,101,:1
4Short in vitro halflife of Thymopoietin32-36 pentapeptide in human plasma显示文摘Tischio JP Patrick JE Weintraub HS 1979Int J Peptide Protein Res1979,14,:1
5Idemifying the vulnerable patient with rupture-prone plaque显示文摘Weintraub HS 2008Cardiol2008,101,12:1
6Treating systolic hypertension in the very elderly with valsartan hydrochlorothiazide vs either monotherapy:ValVET primary results显示文摘Izzo JL Jr Weintraub HS Duprez DA 0,,:1
7Short in vitro half-life of thymopoietin 32-36 pentapeptide in human plasma显示文摘TISCHIO JP PATRICK JE WEINTRAUB HS 1979Int J Pept Protein Res1979,14,5:1
8Short in vitro half-life of thymopoietin 32 - 36 pentapeptide in human plasma 显示文摘Tischio JP Patrick JE Weintraub HS 1979Int J Pept Protein lles1979,14,:1
9Role of RAAS Inhibition in the Prevention of Cardiovascular Disease显示文摘Tran HA Schwartzbard A Weintraub HS 2011Curr Treat Options Cardiovasc Med2011,13,4:1
10Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiaz- ide vs either monotherapy; VatVET primary results显示文摘Izzo JL Jr Weintraub HS Duprez DA 2011J Clin Hypertens (Greenwich)2011,13,10:1
11Role of RAAS inhi- bition in the prevention of cardiovascular discase显示文摘Tran HA Schwartzbard A Weintraub HS 2011Curt Treat Options Cardiovase Med2011,3,4:1
12Identifying the vulnerable patient with rupture-prone plaque 显示文摘Weintraub HS 2008Am J Cardiol2008,101,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费